Canakinumab Subcutaneous and Lamictal ODT
Determining the interaction of Canakinumab Subcutaneous and Lamictal ODT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: lamotrigine
Brand name: Lamictal, Lamictal ODT, Lamictal XR, Subvenite, Lamictal, Lamictal ODT, Lamictal XR, Lamictal CD, LaMICtal Starter Kit, LaMICtal ODT Patient Titration Kit, LaMICtal XR Patient Titration Kit, LamoTRIgine Starter Kit, Subvenite Starter Kit
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Lamictal XR
- Canakinumab Subcutaneous-Lamisil
- Canakinumab Subcutaneous-Lamisil Oral Granules
- Canakinumab Subcutaneous-Lamivudine
- Canakinumab Subcutaneous-Lamivudine and tenofovir
- Canakinumab Subcutaneous-Lamivudine and Tenofovir Disoproxil Fumarate
- Lamictal ODT-Canasa
- Lamictal ODT-Canasa Pac rectal
- Lamictal ODT-Canasa rectal
- Lamictal ODT-Cancidas
- Lamictal ODT-Candesartan
- Lamictal ODT-Candesartan and Hydrochlorothiazide